Sai Parenterals Appoints Auditors and Authorizes Strategic Growth Exploration Following Board Meeting

Sai Parenterals Appoints Auditors and Authorizes Strategic Growth Exploration Following Board Meeting

Sai Parenterals Appoints Auditors and Authorizes Strategic Growth Exploration Following Board Meeting​

Sai Parenterals Limited announced that its Board of Directors held a meeting on Monday, July 6, 2026. The meeting considered and approved several key appointments related to the company's governance and future operational strategy.

The company appointed external professionals for various critical roles, including secretarial, internal, and cost audits. These appointments cover different financial years and specific functions required by the business.

A summary of the professional appointments decided during the Board meeting is detailed in the table below:

Auditor/ConsultantRoleAppointment Period
M/s. Aakanksha Dubey & Co.Secretarial AuditorsFive (5) Financial Years, from 2026-27 to 2030-31
M/s. NSVR & Associates LLPInternal AuditorsFinancial Year 2026-27
M/s. Sai Krishna & AssociatesCost AuditorsFinancial Year 2026-27

M/s. Aakanksha Dubey & Co., a practicing company secretary firm, was appointed as the Secretarial Auditors for five financial years, from 2026-27 to 2030-31. M/s. NSVR & Associates LLP was appointed as Internal Auditors for the Financial Year 2026-27, while M/s. Sai Krishna & Associates was appointed as Cost Auditors for the same financial year.

The appointments were formalized on July 6, 2026. M/s. Aakanksha Dubey & Co. and M/s. NSVR & Associates LLP both possess extensive experience in relevant corporate functions and compliance frameworks. M/s. Sai Krishna & Associates is noted for its specialized services in cost audits and financial advisory across diverse industries.

In addition to governance appointments, the Board meeting authorized Mr. Anil Kumar Karusala, Chairman and Managing Director of the company, to evaluate and identify suitable growth opportunities. This authorization covers both organic and inorganic avenues within the existing line of business or other strategic areas deemed beneficial to Sai Parenterals Limited.

SAIPARENT Stock Price Movement​

Sai Parenterals Limited slipped by 1.41% today, closing at ₹609.90 following post-market trading session. The stock traded a volume of 297,411 shares during the day, which saw its low touch at ₹606.05.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top